Accomplished global strategic operational business leader and investor with over 20 years of corporate development and strategy leadership, and both venture and growth-equity investment experience, in the industrial biotechnology, food and agritech, and life sciences sectors. Dr. Huot has demonstrable expertise in scaling organizations to achieve strong financial returns within an innovation-driven environment in multiple industries, and drive positive social and environmental impacts. Dr. Huot is the former COO of Calysta, a world-leading alternative protein producer via gas-based fermentation, and former co-Managing Director of Calysseo JV, a 50/50 JV between Calysta and Adisseo (a China National BlueStar company). Calysseo constructed and operates the first industrial scale Single Cell Protein manufacturing plant in the world with a 20,000 tonnes/year capacity in Chongqing, China. From 2004 to 2016, Dr. Huot was Managing Director – Head of Industrial Biosciences, Food and Agritech Practice Group and member of the Investment Committee at VantagePoint Capital Partners, a global venture and growth-equity investment fund with over US$4 billion under management, focusing on sustainability, energy innovation and efficiency. Prior to joining VantagePoint Capital Partners, Dr. Huot was an Investment Analyst at CDPQ, one of Canada’s leading institutional fund managers with US$390 billion in net assets, is a long-term institutional investor that invests globally in major financial markets, private equity, infrastructure, real estate, and private debt. Dr. Huot received his Ph.D. in Biochemistry and Molecular Biology from University College London (U.K.).